Status:
COMPLETED
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Precancerous Condition
Eligibility:
All Genders
18-90 years
Brief Summary
RATIONALE: A study that evaluates DNA changes and other disease-related health information in patients with Barrett's esophagus, gastroesophageal reflux, or gastrointestinal bleeding may help doctors ...
Detailed Description
OBJECTIVES: * Assess the role of several genetically determined factors that, in combination with CagA status, cigarette smoking, alcohol, and diet to varying degrees, result in an increased risk for...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Undergoing elective esophagogastroduodenoscopy for any of the following reasons:
- Surveillance of Barrett's esophagus
- Evaluation of severe or refractory gastroesophageal reflux disease or chest pain thought to be due to reflux
- Gastrointestinal bleeding
- PATIENT CHARACTERISTICS:
- Not pregnant
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT00445653
Start Date
August 1 2005
End Date
March 1 2013
Last Update
January 18 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114
2
Harvard School of Public Health
Boston, Massachusetts, United States, 02115